Global Blood Therapeutics, Inc

United States

pre-ipo

Stage

About

Global Blood Therapeutics, Inc is a biopharmaceutical company focused on discovering, developing, and delivering therapies for sickle cell disease and other serious blood disorders.

Explore Global Blood Therapeutics, Inc's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.